Abreaction for conversion disorder: Systematic review with meta-analysis

British Journal of Psychiatry

Volumn 197, Issue 2, 2010, Pages 91-95

  Poole, Norman A ^a   Wuerz, Axel ^b   Agrawal, Niruj ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b MARMARA UNIVERSITY   (Turkey)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METHYLPHENIDATE; MIDAZOLAM;

ADULT; CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CONVERSION DISORDER; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PSYCHOTHERAPY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW;

ABREACTION; BARBITURATES; BENZODIAZEPINES; CONVERSION DISORDER; DRUG THERAPY, COMBINATION; FEMALE; GABA MODULATORS; HUMANS; MALE; PLACEBOS; REPRESSION, PSYCHOLOGY; SUGGESTION;

EID: 77955355797     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.066894     Document Type: Review

References (84)

1. Bass C, Peveler R, House A. Somatoform disorders: severe psychiatric illnesses neglected by psychiatrists. Br J Psychiatry 2001; 179: 11-14. (Pubitemid 32613391)
2. Slater ET, Glithero E. A follow-up of patients diagnosed as suffering from 'hysteria'. J Psychosom Res 1965; 9: 9-13.
3. Crimlisk HL, Bhatia K, Cope H, David A, Marsden CD, Ron MA. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 1998; 316: 582-6.
4. Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, et al. Systematic review of misdiagnosis of conversion symptoms and 'hysteria'. BMJ 2005; 331: 989.
5. Carson AJ, Best S, Postma K, Stone J, Warlow C, Sharpe M. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003; 74: 897-900. (Pubitemid 36782991)
6. Ruddy R, House A. Psychosocial interventions for conversion disorder. Cochrane Database Syst Rev 2005; 4: CD005331.
7. Horsley JS. Narco-analysis. A New Technique in Short-cut Psychotherapy: A Comparison with other Methods and Notes on the Barbiturates. Oxford University Press, 1943.
8. Tilkin L. The present status of narcosynthesis using sodium pentothal and sodium amytal. Dis Nerv Syst 1949; 10: 215.
9. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med 2001; 134: 330-4.
10. Trabert W. 100 years of delusional parasitosis. Meta-analysis of 1,223 case reports. Psychopathology 1995; 28: 238-46.
11. Lambert C, Rees WL. Intravenous barbiturates in the treatment of hysteria. BMJ 1940; 2: 70-3.
12. Semenov H. Deafness of psychic origin and its response, to narcosynthesis. Trans Am Ophthalmol Otolaryngol 1947; 2: 326-48.
13. Lal N, Sharma M. Role of narcosuggestions in hysteria. Indian J Psychiatry 1978; 20: 71-5.
14. Hafeiz HB. Hysterical conversion: a prognostic study. Br J Psychiatry 1980; 136: 548-51.
15. Carter AB. The prognosis of certain hysterical symptoms. BMJ 1949; 1: 1076-9.
16. Horsley JS. Narco-analysis. J Ment Sci 1936; 82: 416-22.
17. Herman M. The use of intravenous sodium amytal in psychogenic amnestic states. Psychiatr Q 1938; 12: 738-42.
18. Wilde JF. Narco-analysis in the treatment of war neuroses. BMJ 1942; 2: 4-7.
19. Sullivan DJ. Psychiatric uses of intravenous sodium amytal. Am J Psychiatry 1942; 99: 411-8.
20. Morris DP. Intravenous barbiturates: an aid in the diagnosis and treatment of conversion disorder and malingering. Mil Surg 1945; 96: 509-18.
21. Greiber MF. Narcosynthesis in the treatment of the noncombatant psychiatric casualty overseas. War Med 1945; 8: 85-90.
22. Bender MB, O'Brien FH. The influence of barbiturate on various forms of nystagmus. Am J Ophthalmol 1946; 29: 1541-52.
23. Rosen H, Myers H. Abreaction in the military setting. Arch Neurol Psychiatry 1947; 57: 161-72.
24. Hannah HB. The treatment of hysteria by narco-hypnosis. Minn Med 1947; 30: 305-9.
25. Myerson A. The treatment of hysteric amnesia by purely pharmacologic means. N Engl J Med 1947; 236: 821-3.
26. Ripley HS, Wolf S. The intravenous use of sodium amytal in psychosomatic disorders. Psychosom Med 1947; 9: 260-8.
27. Kupper WH. Observations on the use of a phonograph record of battle sounds employed in conjunction with pentothal in the treatment of 14 cases of severe conversion hysteria caused by combat. J Nerv Ment Dis 1947; 105: 56-60.
28. Shorvon HJ, Sargant W. Excitatory abreaction: with special reference to its mechanism and the use of ether. J Ment Sci 1947; 393: 709-32.
29. Mueller EE, Kaney EM. Demonstrative clinical teamwork in the treatment of conversion hysteria. Psychiatr Q 1947; 21: 431-46.
30. Fisher C, Joseph ED. Fugue with awareness of loss of personal identity. Psychoanal Q 1949; 18: 480-93.
31. Arentsen K. Psychogenic deafness: a survey and a psychiatric study. Acta Psychiatr Neurol Scand 1954; 29: 391-410.
32. King PF. Psychogenic deafness. J Laryngol Otol 1954; 68: 623-35.
33. Mann J. The use of sodium amobarbital in psychiatry. Ohio Med J 1969; 65: 700-2.
34. Hoffman PB, Faris AM. Psychiatric interventions with amnestic aircraft accident survivors. Aerospace Med 1974; 45: 1286-90.
35. Wettstein RM, Fauman BJ. The amobarbital interview. Ann Emerg Med 1979; 8: 272-4.
36. Iserson KV. The emergency amobarbital interview. Ann Emerg Med 1980; 9: 27-31.
37. Shale JH, Gelenberg AJ. The amobarbital interview. Mil Med 1980; 145: 825-8.
38. Perry JC, Jacobs D. Overview: clinical applications of the amytal interview in psychiatric emergency settings. Am J Psychiatry 1982; 139: 552-9.
39. Chancellor AM, Fraser AR. Dissociative disorder, conversion disorder and the use of abreaction in a 22 year old male. N Z Med J 1982; 95: 418-9.
40. Schwartze GM, Mchenry LC, Proctor RC. Convergence spasm - treatment by amytal interview. J Clin Neuroophthalmol 1983; 3: 123-5.
41. Weller EB, Weller RA. Case report of conversion symptom associated with major depressive disorder in a child. Am J Psychiatry 1983; 140: 1079-80.
42. Markowitz J, Viederman M. A case of dissociative pseudodementia. Gen Hosp Psychiatry 1986; 8: 87-90.
43. Stevens H. Is it organic or is it functional? Is it hysteria or is it malingering? Psychiatr Clin North Am 1986; 9: 241-54.
44. Marcum JM, Wright K, Bissell WG. Chance discovery of multiple personality disorder in a depressed patient by amobarbital interview. J Nerv Ment Dis 1986; 174: 489-92.
45. Hendler N, Filtzer D, Talo S, Panzetta M, Lond D. Hysterical scoliosis treated with amobarbital narcosynthesis. Clin J Pain 1987; 2: 179-82.
46. White A, Corbin DOC, Coope B. The use of thiopentone in the treatment of non-organic locomotor disorder. J Psychosom Res 1988; 32: 249-53.
47. Hurwitz TA. Narcosuggestion in chronic conversion symptoms using combined intravenous amobarbital and methylphenidate. Can J Psychiatry 1988; 33: 147-52.
48. Menza MA. A suicide attempt following removal of conversion paralysis with amobarbital. Gen Hosp Psychiatry 1989; 11: 137-9.
49. Freimer N, Lu F, Chen J. Posttraumatic stress and conversion disorders in a maotian refugee veteran: use of amobarbital interviews. J Nerv Ment Dis 1989; 177: 432-3.
50. Hurwitz TA. Ideogenic neurological deficits: conscious mechanisms in conversion symptoms. Neuropsychiatry Neuropsychol Behav Neurol 1989; 1: 301-8.
51. Stevens CB. Lorazepam in the treatment of acute conversion disorder. Hosp Community Psychiatry 1990; 41: 1255-7.
52. Ellis SJ. Diazepam as a truth drug. Lancet 1990; 336: 752-3.
53. Matas M. Psychogenic voice disorders: literature review and case report. Can J Psychiatry 1991; 36: 363-5.
54. Sengupta SN, Jena S, Saxena S. Generalised dissociative amnesia. Aust NZ J Psychiatry 1993; 27: 699-700.
55. Stiebel VG. The amytal interview in the treatment of conversion disorder: three case reports. Mil Med 1994; 159: 350-53.
56. Kopelman MD, Christensen H, Puffett A, Stanhope N. The great escape: neuropsychological study of psychogenic amnesia. Neuropsychologia 1994; 32: 675-91.
57. Nicolson R, Feinstein A. Conversion, dissociation, and multiple sclerosis. J Nerv Ment Dis 1994; 182: 668-9.
58. Fochtmann LJ. Intractable sneezing as a conversion symptom. Psychosomatics 1995; 36: 103-12.
59. Graham C, Thavasotby R. Dissociative psychosis: an atypical presentation and response to cognitive-analytic therapy. Ir J Psychol Med 1995; 12: 109-11.
60. Bradley RH, Zonia CL, Caputo SJ. The amobarbital sodium interview in conversion disorders: use of video feedback in therapy. J Am Osteopath Assoc 1995; 95: 122-5.
61. Fackler SM, Anfinson TJ, Rand JA. Serial sodium amytal interviews in the clinical setting. Psychosomatics 1997; 38: 558-64.
62. Al-Samarrai SH, Kramer E, Newmark T. Palilalia as a conversion disorder. Psychosomatics 2001; 42: 277-8.
63. Ballew L, Morgan Y, Lippmann S. Intravenous diazepam for dissociative disorder: memory lost and found. Psychosomatics 2003; 44: 346-7.
64. Ilechukwu STC, Henry T. Amytal interview using intravenous lorazepam in a patient with dissociative fugue. Gen Hosp Psychiatry 2006; 28: 544-5.
65. Vattakatuchery JJ, Cesterman P. The use of abreaction to recover memories in psychogenic amnesia: a case report. J Forensic Psychiatry Psychol 2006; 17: 647-53.
66. Kirsch I. Hypnosis and placebos: response expectancy as a mediator of suggestion effects. Anales de Psicologia 1999; 15: 99-110.
67. Merskey H. The Analysis of Hysteria: Understanding Conversion and Dissociation. Gaskell, 1995.
68. Janet P. The Major Symptoms of Hysteria: Fifteen Lectures Given in The Medical School of Harvard University. Macmillan & Co, 1907.
69. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiology 2000; 53: 786-92.
70. Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 2004; 130: 324-40.
71. Eysenck HJ, Rees WL. States of heightened suggestibility: narcosis. J Ment Sci 1945; 91: 301-10.
72. Jones E. Sigmund Freud: Life and Work, Vol. 1. Hogarth Press, 1953.
73. Freud S, Breuer J. Studies in Hysteria. Penguin Books, 2004.
74. Freud S. The Origins of Psycho-Analysis. Letters to Wilhelm Fliess, Drafts and Notes: 1887-1902. Basic Books, 1954.
75. McDougall W. The revival of emotional memories and its therapeutic value (III). Br J Med Psychol 1920; 1: 23-9.
76. van der Hart O, Brown P. Abreaction re-evaluated. Dissociation 1992; 5: 127-40.
77. Craig TKJ. Life events: meanings and precursors. In Contemporary Approaches to the Study of Hysteria: Clinical and Theoretical Perspectives (eds P Halligan, C Bass, JC Marshall): 88-101. Oxford University Press, 2001.
78. Naples M, Hackett TP. The amytal interview: history and current uses. Psychosomatics 1978; 19: 98-105. (Pubitemid 9070455)
79. Binzer M, Kullgren G. Motor conversion disorder - a prospective 2-5 year follow-up study. Psychosomatics 1998; 39: 519-27.
80. Ron MA. The prognosis of hystera/somatization disorder. In Contemporary Approaches to the Study of Hysteria: Clinical and Theoretical Perspectives (eds P Halligan, C Bass, JC Marshall): 271-82. Oxford University Press, 2001.
81. Kavirajan H. The amobarbital interview revisited: a review of the literature since 1966. Harv Rev Psychiatry 1999; 7: 153-65.
82. Mace CJ, Trimble MR. Ten-year prognosis of conversion disorder. Br J Psychiatry 1996; 169: 282-8.
83. Sargant W, Slater E. An Introduction to Physical Methods of Treatment in Psychiatry. Churchill Livingstone, 1944.
84. Chodoff P. The diagnosis of hysteria: an overview. Am J Psychiatry 1974; 131: 1073-8.